To ask the Scottish Executive, further to the answer to question S1O-3462 by Susan Deacon on 24 May 2001, whether it will ensure that every patient who is assessed as potentially benefiting from beta interferon is prescribed it. (S1O-3554)
Official Report · Chamber
Beta Interferon
Question Time SCOTTISH EXECUTIVE
Speakers
Choose an MSP to read only their contributions- Tricia Marwick SNP 3
- Susan Deacon Lab 2
- Sir David Steel 1
The record
6 contributionsThe Executive has initiated an extensive agenda of work to ensure that all patients have access to consistent, high-quality NHS services, no matter where in the country they live.
I have commissioned expert advice on the use of beta interferon, which is expected later this year. The NHS in Scotland will get the best possible clinical advice based on the widest evidence available. I expect health boards and trusts to follow that national advice when delivering care to their patients with multiple sclerosis.
I have commissioned expert advice on the use of beta interferon, which is expected later this year. The NHS in Scotland will get the best possible clinical advice based on the widest evidence available. I expect health boards and trusts to follow that national advice when delivering care to their patients with multiple sclerosis.
Two weeks ago, the minister said that cost was not a factor in determining whether patients with MS are prescribed beta interferon.
Will Susan Deacon explain why 52 people in greater Glasgow have been clinically assessed as requiring beta interferon, but have not been prescribed it because the funding has not been made available? Will she also explain why no new prescriptions for beta interferon have been issued in the Greater Glasgow Health Board area since November 1998? Will she explain why she has constantly claimed that cost limits are not being applied when she knows that that is not true?
Will Susan Deacon explain why 52 people in greater Glasgow have been clinically assessed as requiring beta interferon, but have not been prescribed it because the funding has not been made available? Will she also explain why no new prescriptions for beta interferon have been issued in the Greater Glasgow Health Board area since November 1998? Will she explain why she has constantly claimed that cost limits are not being applied when she knows that that is not true?
If Tricia Marwick were to check the Official Report from a few weeks ago, I suspect that she would probably find that I said that this is not simply a question of cost; as with any drug or treatment, it is a matter of considering the clinical effectiveness and cost-effectiveness of any intervention. Every health care system in the world has to do that. We have to find systems, especially when modern medicine and technology are advancing by the day, of evaluating drugs and treatments to ensure that what we offer in the NHS in this country are the best interventions for all concerned.
As far as multiple sclerosis and beta interferon are concerned, as the member knows full well, measures have been put in place across the UK to assess beta interferon, through the National Institute for Clinical Excellence and the Health Technology Board for Scotland. It is right and proper that that is done in an effective way. It is right and proper that the best possible evidence and clinical advice is available to the NHS in Scotland. We will continue to take that work forward in a balanced and measured way.
As far as multiple sclerosis and beta interferon are concerned, as the member knows full well, measures have been put in place across the UK to assess beta interferon, through the National Institute for Clinical Excellence and the Health Technology Board for Scotland. It is right and proper that that is done in an effective way. It is right and proper that the best possible evidence and clinical advice is available to the NHS in Scotland. We will continue to take that work forward in a balanced and measured way.
On a point of order, Presiding Officer.
May I quote the minister, who said in the Official Report—
May I quote the minister, who said in the Official Report—
Sir David Steel
The Presiding Officer · Lothians
link
No, I am sorry. That is not a point of order.
In this meeting
Everything on 6 Jun 2001 →- Scottish Parliament Wednesday 6 June 2001 (Afternoon) Debate · 1
- Time for Reflection Time for reflection · 2
- Parliamentary Bureau Motions Business motions · 10
- Business Motion Business motions · 40
- Committee of the Whole Parliament Debate · 1
- Scottish Local Authorities (Tendering) Bill: Stage 2 Bill debate · 5
- Scottish Parliament Debate · 1
- Scottish Local Authorities (Tendering) Bill: Stage 3 Bill debate · 8
- New Deal Questions · 6
- Policing Questions · 8
- Violence Against Women Questions · 8
- Science Strategy Questions · 8
- Out-of-school Learning Questions · 4
- Cultural and Heritage Sites Questions · 9
- Energy Efficiency Questions · 6
- Breast Cancer Questions · 13
- Prawn Shells (Recycling) Questions · 4
- Beta Interferon Questions · 6
- Local Democracy Questions · 13
- Scottish Budget Questions · 8
- Schools (Technological Studies) Questions · 4
- Prime Minister (Meetings) First Minister’s Questions · 8
- Secretary of State for Scotland (Meetings) First Minister’s Questions · 9
- Schools First Minister’s Questions · 6
- Motorola First Minister’s Questions · 6
- Universities (Applications) First Minister’s Questions · 6
- Motion Without Notice Business motions · 11
- Decision Time Decision time · 9
- Prescription Charges (Exemptions) Members’ business · 14
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.